Third Rock Ventures is a venture capital firm with offices in Boston and San Francisco.[1] Founded in 2007, the firm invests in biotechnology startups.[2]
Funding and investments
Third Rock Ventures has raised $3.8 billion since it was created and invested in more than 60 companies, including Sage Therapeutics, Editas Medicine, Constellation Pharmaceuticals and Flare Therapeutics.[3][4]
References
- Allison DeAngelis. Third Rock Ventures plots next chapter after raising $1.1 billion fund STAT, retrieved 16 April 2024^
- Luke Timmeran. Third Rock Ventures, One of Biotech's Daring Investors, Raises $616M For More Startups Forbes, 31 October 2016, retrieved 22 August 2018^
- Mark Terry. In Tough Biotech Market, Third Rock Raises New $1.1B Fund BioSpace, retrieved 16 April 2024^
- Allison DeAngelis. Third Rock Ventures plots next chapter after raising $1.1 billion fund STAT, retrieved 16 April 2024^